Emergent BioSolutions Shares up 9.2% Premarket as Mpox Cases Reported Outside of Africa
Emergent Biosolutions股价在非洲国外报告的Mpox病例的影响下,盘前上涨9.2%。
Emergent BioSolutions Shares up 9.2% Premarket as Mpox Cases Reported Outside of Africa
Emergent Biosolutions股价在非洲国外报告的Mpox病例的影响下,盘前上涨9.2%。
使用浏览器的分享功能,分享给你的好友吧